Author

O. Veiseh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

A. Curtiss· 1 shared A. Feinberg· 1 shared A. R. DiNardo· 1 shared A. Singh Mehta· 1 shared A. Surendran· 1 shared Abhimanyu· 1 shared B. Mahata· 1 shared B. Rothrock· 1 shared

Activity by Year

2023-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Curtiss

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Uncovering the Interleukin-12 Pharmacokinetic Desensitization Mechanism and Its Consequences with Mathematical Modeling

J. DeBonis, O. Veiseh, O. A. Igoshin

This paper develops a mathematical model to explain IL-12 pharmacokinetic desensitization, showing that reduced bioavailability, not increased clearance, best explains clinical data.

CPT: Pharmacometrics & Systems Pharmacology · Oct 16, 2024Peer-reviewedBioengineering

Persistent tailoring of MSC activation through genetic priming

M. A. Beauregard, G. C. Bedford, D. A. Brenner, L. D. Sanchez Solis, T. Nishiguchi, Abhimanyu, S. Carrero Longlax, B. Mahata, O. Veiseh, P. L. Wenzel, A. R. DiNardo, I. B. Hilton, M. R. Diehl

This paper introduces a genetic priming method using IRF1 to sustainably enhance MSC potency and suppress immunogenicity compared to biochemical priming.

bioRxiv · Feb 1, 2024Bioengineering

Electrocatalytic on-site oxygenation for transplanted cell-based-therapies

I. Lee, A. Surendran, S. Fleury, I. Gimino, A. Curtiss, C. Fell, D. Shiwarski, O. El-Refy, B. Rothrock, S. Jo, T. Schwartzkopff, A. Singh Mehta, S. John, X. Ji, G. Nikiforidis, , T. Cohen-Karni

This paper introduces an electrocatalytic system for on-site oxygen production to support cell therapies under hypoxic conditions.

bioRxiv · Jun 5, 2023Bioengineering